Stanford Medicine offers gene therapy for a devastating pediatric neurologic disease Stanford Medical Center Report Nawigacja wpisu I’ve been practicing medicine at a renowned institution for 40 years. Society isn’t ready for us to reverse the aging … – Fortune Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 … – Nature.com
